A carregar...
Safety and efficacy of durvalumab (MEDI4736) in various solid tumors
INTRODUCTION: The prominent immune checkpoint molecule, programmed cell death ligand-1 (PD-L1), is the object of increasing attention. Here, we report a meta-analysis investigating the safety and efficacy of durvalumab (MEDI4736), an inhibitor of PD-L1, in various solid tumors. METHODS: A systematic...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6038862/ https://ncbi.nlm.nih.gov/pubmed/30013326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S162214 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|